drug · small molecule
tafenoquine succinate
Marketedupdated 3mo agoby $SXTP 60 DEGREES PHARMACEUTICALS, INC.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for malaria and plasmodium vivax malaria.
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 2, 2035
~9.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Dec 2, 2035method-of-use (U-2582)US 10342791
- Dec 2, 2035method-of-use (U-2582)US 10888558
- Dec 2, 2035method-of-use (U-2582)US 11744828
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 23m ago
Found something off?
comments(0)
5-min edit window · permanent after that